Form S-3 Clearpoint Neuro Inc For: 14 January
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Clearpoint Neuro Inc (CLPT)
Assess today's live Clearpoint Neuro Inc (CLPT) share price, performance and insights using our live NASDAQ: CLPT stock exchange data.
Analyse the historical data and Clearpoint Neuro Inc share price performance charts on this page. Our technical summary section provides analysis on Clearpoint Neuro share price buy/sell indicators using real-time data (or discuss the Clearpoint Neuro (CLPT) stock price today with other investors in the Clearpoint Neuro NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CLPT share price (ISIN: US18507C1036) to enhance your trading decisions with our free investment tools and resources.
What Is the Clearpoint Neuro Inc Share Price Today?
The Clearpoint Neuro share price today is 14.01.
What Is the Stock Symbol for Clearpoint Neuro Inc
The stock symbol (or 'ticker') for Clearpoint Neuro Inc is "CLPT."
What Stock Exchange Does Clearpoint Neuro Inc Trade On?
Clearpoint Neuro Inc is listed and trades on the NASDAQ stock exchange.
Is Clearpoint Neuro Inc a Good Stock to Buy?
Determining whether Clearpoint Neuro Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Clearpoint Neuro Inc share price performance charts on this page. Our technical summary section provides analysis on Clearpoint Neuro share price buy/sell indicators using real-time data (or discuss the Clearpoint Neuro (CLPT) stock price today with other investors in the Clearpoint Neuro NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CLPT share price (ISIN: US18507C1036) to enhance your trading decisions with our free investment tools and resources.
What Is the Clearpoint Neuro Inc Share Price Today?
The Clearpoint Neuro share price today is 14.01.
What Is the Stock Symbol for Clearpoint Neuro Inc
The stock symbol (or 'ticker') for Clearpoint Neuro Inc is "CLPT."
What Stock Exchange Does Clearpoint Neuro Inc Trade On?
Clearpoint Neuro Inc is listed and trades on the NASDAQ stock exchange.
Is Clearpoint Neuro Inc a Good Stock to Buy?
Determining whether Clearpoint Neuro Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.51
14.17
52 wk Range
9.76
30.10
CLPT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.5114.17
52 wk Range
9.7630.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CLPT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
29.00
Upside
+107.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- ClearPoint Neuro reports 20% sales growth in Q4 2025
- Investing.com
- Form S-3 Clearpoint Neuro Inc For: 14 January
- Investing.com
- ClearPoint Neuro reports 20% sales growth in Q4 2025
- Investing.com
- Form 144 ClearPoint Neuro For: 9 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Clearpoint Neuro Company Profile
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Clearpoint Neuro Inc Earnings Call Summary for Q3/2025
- ClearPoint Neuro (CLPT) missed Q3 2025 forecasts with $8.9M revenue (9.59% below expectations) and -$0.21 EPS, triggering a 6.89% stock drop in after-hours trading.
- Despite overall misses, the company reported 9% YoY revenue growth, with Neurosurgery Navigation and Therapy segment up 20% and improved gross margin of 63% (from 60% in Q3 2024).
- The company maintained its 2025 revenue forecast of $36-38M and projected 2026 pro forma revenue between $54-60M despite current challenges.
- CEO Joe Burnett characterized the company as 'effectively pre-revenue in this phase,' emphasizing a strategic vision targeting $500M in annual revenue.
- Strategic initiatives include expanding the CRO facility and integrating operations with IRRAS, though analysts noted potential integration challenges in a competitive neurosurgical navigation market.
Last Updated: 14/11/2025, 13:24
Read Full TranscriptCompare CLPT to Peers and Sector
Metrics to compare | CLPT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCLPTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −18.0x | −3.0x | −0.6x | |
PEG Ratio | 0.91 | −0.15 | 0.00 | |
Price/Book | 26.3x | 4.7x | 2.6x | |
Price / LTM Sales | 12.1x | 3.0x | 3.4x | |
Upside (Analyst Target) | 108.6% | 29.4% | 42.5% | |
Fair Value Upside | Unlock | 2.7% | 5.8% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 29.00
(+107.00% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
-0.21 / -0.18
Revenue / Forecast
8.86M / 9.80M
People Also Watch
FAQ
What Is the Clearpoint Neuro (CLPT) Share Price Today?
The live Clearpoint Neuro share price today is 14.01
What Stock Exchange Does Clearpoint Neuro (CLPT) Trade On?
Clearpoint Neuro is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Clearpoint Neuro?
The stock symbol (also called a 'ticker') for Clearpoint Neuro is "CLPT."
What Is the Current Clearpoint Neuro Market Cap?
As of today, Clearpoint Neuro market capitalisation is 416.77M.
What Is Clearpoint Neuro's (CLPT) Earnings Per Share (TTM)?
The Clearpoint Neuro EPS is currently -0.83 (Trailing Twelve Months).
When Is the Next Clearpoint Neuro Earnings Date?
Clearpoint Neuro's next earnings report will be released on 04 Mar 2026.
Is CLPT a Buy or Sell From a Technical Analyst Perspective?
Based on today's Clearpoint Neuro moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Clearpoint Neuro Stock Split?
Clearpoint Neuro has split 1 times. (See the CLPT stock split history page for full effective split date and price information.)
How Many Employees Does Clearpoint Neuro Have?
Clearpoint Neuro has 115 employees.
What is the current trading status of Clearpoint Neuro (CLPT)?
As of 22 Jan 2026, Clearpoint Neuro (CLPT) is trading at a price of 14.01, with a previous close of 13.90. The stock has fluctuated within a day range of 13.51 to 14.17, while its 52-week range spans from 9.76 to 30.10.
What Is Clearpoint Neuro (CLPT) Price Target According to Analysts?
The average 12-month price target for Clearpoint Neuro is USD29.00, with a high estimate of USD30 and a low estimate of USD28. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +107.00% Upside potential.
What Is the CLPT Premarket Price?
CLPT's last pre-market stock price is 14.11. The pre-market share volume is 6,140.00, and the stock has decreased by 0.21, or 1.51%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.